| 0 |
CEREBRAL CANDIDIASIS |
11 |
0.7333 |
| 1 |
GLUTATHIONE REDUCTASE ACTIVITY INCREASED |
1 |
0.3333 |
| 2 |
URINARY SYSTEM X-RAY |
1 |
0.3333 |
| 3 |
BURKITT'S LYMPHOMA STAGE III |
1 |
0.1250 |
| 4 |
ACUTE LYMPHOCYTIC LEUKAEMIA (IN REMISSION) |
2 |
0.1053 |
| 5 |
STOMATOCOCCAL INFECTION |
12 |
0.0968 |
| 6 |
RHABDOID TUMOUR |
5 |
0.0962 |
| 7 |
PRIMITIVE NEUROECTODERMAL TUMOUR |
5 |
0.0926 |
| 8 |
BURKITT'S LEUKAEMIA |
1 |
0.0909 |
| 9 |
LYMPHOID TISSUE HYPOPLASIA |
11 |
0.0719 |
| 10 |
THYMUS HYPOPLASIA |
10 |
0.0575 |
| 11 |
LIPOSARCOMA METASTATIC |
1 |
0.0435 |
| 12 |
RESPIRATORY MONILIASIS |
11 |
0.0410 |
| 13 |
PYOMYOSITIS |
12 |
0.0405 |
| 14 |
ENDOMETRIAL STROMAL SARCOMA |
2 |
0.0400 |
| 15 |
BURKITT'S LYMPHOMA |
4 |
0.0381 |
| 16 |
OSTEOSARCOMA METASTATIC |
3 |
0.0316 |
| 17 |
OSTEOSARCOMA |
12 |
0.0312 |
| 18 |
CUTANEOUS MUCORMYCOSIS |
5 |
0.0272 |
| 19 |
HUMAN HERPESVIRUS 6 VIRAEMIA |
1 |
0.0250 |
| 20 |
DISSEMINATED ASPERGILLOSIS |
11 |
0.0233 |
| 21 |
BILE ACIDS INCREASED |
4 |
0.0226 |
| 22 |
SKIN CANDIDA |
11 |
0.0211 |
| 23 |
JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA |
1 |
0.0196 |
| 24 |
SEROCONVERSION TEST POSITIVE |
1 |
0.0189 |
| 25 |
TROPONIN |
1 |
0.0179 |
| 26 |
PERONEAL NERVE INJURY |
2 |
0.0177 |
| 27 |
RETINOIC ACID SYNDROME |
3 |
0.0174 |
| 28 |
BLOOD BETA-D-GLUCAN INCREASED |
5 |
0.0163 |
| 29 |
LUNG ASSIST DEVICE THERAPY |
1 |
0.0161 |
| 30 |
FLAGELLATE DERMATITIS |
1 |
0.0154 |
| 31 |
INFANTILE DIARRHOEA |
1 |
0.0152 |
| 32 |
INFANTILE VOMITING |
3 |
0.0152 |
| 33 |
PLATELETCRIT DECREASED |
1 |
0.0133 |
| 34 |
AMMONIA DECREASED |
1 |
0.0130 |
| 35 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE ABNORMAL |
1 |
0.0128 |
| 36 |
CHONDROSARCOMA |
2 |
0.0127 |
| 37 |
BREAST INJURY |
2 |
0.0123 |
| 38 |
INFECTIVE MYOSITIS |
2 |
0.0120 |
| 39 |
MYELOID LEUKAEMIA |
6 |
0.0120 |
| 40 |
BONE SARCOMA |
2 |
0.0103 |
| 41 |
BACILLUS TEST POSITIVE |
1 |
0.0101 |
| 42 |
NASAL VESTIBULITIS |
1 |
0.0100 |
| 43 |
OUT OF SPECIFICATION TEST RESULTS |
1 |
0.0100 |
| 44 |
ENTEROBACTER BACTERAEMIA |
3 |
0.0099 |
| 45 |
NEUROBLASTOMA RECURRENT |
2 |
0.0099 |
| 46 |
PARAINFLUENZA VIRUS INFECTION |
1 |
0.0097 |
| 47 |
CHORDOMA |
1 |
0.0097 |
| 48 |
MYCOBACTERIUM CHELONAE INFECTION |
7 |
0.0095 |
| 49 |
ANORECTAL POLYP |
1 |
0.0093 |
| 50 |
PERIPORTAL OEDEMA |
1 |
0.0080 |
| 51 |
PSEUDOMONAL SEPSIS |
14 |
0.0080 |
| 52 |
NEPHROBLASTOMA |
1 |
0.0079 |
| 53 |
AZOOSPERMIA |
3 |
0.0078 |
| 54 |
HEART FAILURE WITH REDUCED EJECTION FRACTION |
4 |
0.0075 |
| 55 |
HORMONE RECEPTOR POSITIVE BREAST CANCER |
2 |
0.0074 |
| 56 |
ANTITHROMBIN III DECREASED |
2 |
0.0073 |
| 57 |
RED BLOOD CELL TRANSFUSION |
3 |
0.0073 |
| 58 |
PH BODY FLUID ABNORMAL |
1 |
0.0072 |
| 59 |
LEUKAEMIC INFILTRATION |
1 |
0.0071 |
| 60 |
OROPHARYNGEAL ERYTHEMA |
1 |
0.0068 |
| 61 |
RADIATION MUCOSITIS |
1 |
0.0062 |
| 62 |
QUADRIPARESIS |
10 |
0.0060 |
| 63 |
OSTEOMYELITIS FUNGAL |
1 |
0.0060 |
| 64 |
SECONDARY IMMUNODEFICIENCY |
7 |
0.0058 |
| 65 |
BASE EXCESS DECREASED |
1 |
0.0056 |
| 66 |
PERICARDIAL EFFUSION MALIGNANT |
1 |
0.0056 |
| 67 |
CANDIDA SEPSIS |
5 |
0.0056 |
| 68 |
SYSTEMIC CANDIDA |
14 |
0.0056 |
| 69 |
ACUTE MONOCYTIC LEUKAEMIA |
1 |
0.0055 |
| 70 |
MEDIASTINAL DISORDER |
2 |
0.0053 |
| 71 |
RHABDOMYOSARCOMA |
1 |
0.0053 |
| 72 |
LARYNGEAL INFLAMMATION |
1 |
0.0053 |
| 73 |
EYE INFECTION FUNGAL |
2 |
0.0052 |
| 74 |
EOSINOPHIL PERCENTAGE DECREASED |
1 |
0.0050 |
| 75 |
ADMINISTRATION SITE EXTRAVASATION |
5 |
0.0050 |
| 76 |
GRANULOCYTES ABNORMAL |
1 |
0.0050 |
| 77 |
TREATMENT RELATED SECONDARY MALIGNANCY |
1 |
0.0049 |
| 78 |
COLONY STIMULATING FACTOR THERAPY |
1 |
0.0048 |
| 79 |
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY |
1 |
0.0047 |
| 80 |
COMPLICATIONS OF TRANSPLANTED HEART |
1 |
0.0047 |
| 81 |
RETICULOCYTE COUNT DECREASED |
2 |
0.0046 |
| 82 |
CARDIAC MYXOMA |
1 |
0.0046 |
| 83 |
PNEUMOCOCCAL SEPSIS |
3 |
0.0046 |
| 84 |
EPSTEIN-BARR VIRAEMIA |
5 |
0.0045 |
| 85 |
ACID BASE BALANCE ABNORMAL |
1 |
0.0045 |
| 86 |
NEUTROPENIA NEONATAL |
1 |
0.0045 |
| 87 |
CAECITIS |
2 |
0.0044 |
| 88 |
URINARY OCCULT BLOOD POSITIVE |
1 |
0.0043 |
| 89 |
PERIPHERAL VEIN THROMBOSIS |
1 |
0.0042 |
| 90 |
APPENDICEAL ABSCESS |
1 |
0.0041 |
| 91 |
ACUTE MYELOMONOCYTIC LEUKAEMIA |
1 |
0.0040 |
| 92 |
BETA 2 MICROGLOBULIN INCREASED |
1 |
0.0038 |
| 93 |
CARDIOTOXICITY |
34 |
0.0038 |
| 94 |
ENTEROCOCCAL BACTERAEMIA |
4 |
0.0038 |
| 95 |
STREPTOCOCCAL BACTERAEMIA |
4 |
0.0037 |
| 96 |
BLOOD CHOLINESTERASE DECREASED |
1 |
0.0036 |
| 97 |
APLASTIC ANAEMIA |
18 |
0.0034 |
| 98 |
PROCALCITONIN INCREASED |
4 |
0.0034 |
| 99 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
6 |
0.0034 |
| 100 |
NAIL TOXICITY |
1 |
0.0033 |
| 101 |
ERYTHROPENIA |
1 |
0.0033 |
| 102 |
STAPHYLOCOCCAL BACTERAEMIA |
14 |
0.0032 |
| 103 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
7 |
0.0031 |
| 104 |
CONDUCTIVE DEAFNESS |
1 |
0.0031 |
| 105 |
COLORECTAL ADENOMA |
1 |
0.0031 |
| 106 |
PERITONEAL DISORDER |
2 |
0.0031 |
| 107 |
HYPERMAGNESAEMIA |
2 |
0.0031 |
| 108 |
ARACHNOIDITIS |
2 |
0.0029 |
| 109 |
METASTASES TO CHEST WALL |
1 |
0.0029 |
| 110 |
FUNGAL TEST POSITIVE |
1 |
0.0028 |
| 111 |
FANCONI SYNDROME |
4 |
0.0028 |
| 112 |
HODGKIN'S DISEASE |
2 |
0.0028 |
| 113 |
ABSCESS BACTERIAL |
1 |
0.0028 |
| 114 |
AXILLARY VEIN THROMBOSIS |
1 |
0.0027 |
| 115 |
BLOOD FIBRINOGEN DECREASED |
3 |
0.0026 |
| 116 |
RADIATION OESOPHAGITIS |
1 |
0.0026 |
| 117 |
NEUROBLASTOMA |
1 |
0.0026 |
| 118 |
CYSTITIS VIRAL |
1 |
0.0026 |
| 119 |
CAPILLARY DISORDER |
1 |
0.0026 |
| 120 |
INTRACRANIAL TUMOUR HAEMORRHAGE |
1 |
0.0026 |
| 121 |
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME |
2 |
0.0026 |
| 122 |
LABORATORY TEST INTERFERENCE |
2 |
0.0025 |
| 123 |
ABDOMINAL SYMPTOM |
2 |
0.0025 |
| 124 |
CYTOMEGALOVIRUS VIRAEMIA |
11 |
0.0025 |
| 125 |
OROPHARYNGEAL PLAQUE |
1 |
0.0025 |
| 126 |
INVASIVE BREAST CARCINOMA |
1 |
0.0024 |
| 127 |
VENOOCCLUSIVE DISEASE |
6 |
0.0024 |
| 128 |
TROPONIN T INCREASED |
3 |
0.0024 |
| 129 |
PLATELET TRANSFUSION |
3 |
0.0023 |
| 130 |
DEVICE LOOSENING |
2 |
0.0023 |
| 131 |
AXONAL NEUROPATHY |
2 |
0.0023 |
| 132 |
PERIPHERAL NERVE INJURY |
2 |
0.0023 |
| 133 |
PNEUMATOSIS |
1 |
0.0022 |
| 134 |
CYSTITIS HAEMORRHAGIC |
9 |
0.0022 |
| 135 |
GRANULOCYTE COUNT DECREASED |
4 |
0.0022 |
| 136 |
FEBRILE NEUTROPENIA |
143 |
0.0022 |
| 137 |
SKIN GRAFT |
2 |
0.0022 |
| 138 |
NEUTROPENIC INFECTION |
2 |
0.0021 |
| 139 |
BLASTOMYCOSIS |
1 |
0.0021 |
| 140 |
INFECTIVE ANEURYSM |
1 |
0.0020 |
| 141 |
HERPES SIMPLEX |
13 |
0.0020 |
| 142 |
MUSCLE CONTRACTIONS INVOLUNTARY |
7 |
0.0020 |
| 143 |
DEVICE RELATED SEPSIS |
4 |
0.0020 |
| 144 |
NEUTROPENIC COLITIS |
4 |
0.0019 |
| 145 |
NEUTROPHIL PERCENTAGE DECREASED |
1 |
0.0019 |
| 146 |
INTERLEUKIN LEVEL INCREASED |
1 |
0.0018 |
| 147 |
VENA CAVA THROMBOSIS |
3 |
0.0018 |
| 148 |
BRAIN SCAN ABNORMAL |
1 |
0.0018 |
| 149 |
LEFT VENTRICULAR DYSFUNCTION |
12 |
0.0018 |
| 150 |
LEUKAEMIA RECURRENT |
3 |
0.0018 |
| 151 |
SUBCLAVIAN VEIN THROMBOSIS |
2 |
0.0018 |
| 152 |
PANCREATITIS NECROTISING |
4 |
0.0017 |
| 153 |
EJECTION FRACTION |
1 |
0.0017 |
| 154 |
LYMPHOPROLIFERATIVE DISORDER |
5 |
0.0017 |
| 155 |
GROIN ABSCESS |
2 |
0.0017 |
| 156 |
ACIDOSIS HYPERCHLORAEMIC |
1 |
0.0017 |
| 157 |
HYPOALBUMINAEMIA |
13 |
0.0017 |
| 158 |
BLOOD CREATININE DECREASED |
5 |
0.0016 |
| 159 |
LIP DISCOLOURATION |
2 |
0.0016 |
| 160 |
GLUCOSE URINE PRESENT |
2 |
0.0016 |
| 161 |
ABDOMINAL COMPARTMENT SYNDROME |
1 |
0.0016 |
| 162 |
ABDOMINAL INFECTION |
4 |
0.0016 |
| 163 |
HYPERCHLORAEMIA |
1 |
0.0016 |
| 164 |
TUMOUR PAIN |
2 |
0.0015 |
| 165 |
CLOSTRIDIUM DIFFICILE COLITIS |
16 |
0.0015 |
| 166 |
ACUTE LEFT VENTRICULAR FAILURE |
1 |
0.0015 |
| 167 |
GLYCOSURIA |
2 |
0.0015 |
| 168 |
HYPERURICAEMIA |
6 |
0.0015 |
| 169 |
EXTRAVASATION |
6 |
0.0015 |
| 170 |
BACTERAEMIA |
17 |
0.0014 |
| 171 |
ALANINE AMINOTRANSFERASE ABNORMAL |
3 |
0.0014 |
| 172 |
PELVIC FLUID COLLECTION |
1 |
0.0014 |
| 173 |
MONOCYTE PERCENTAGE INCREASED |
1 |
0.0014 |
| 174 |
MENINGITIS BACTERIAL |
2 |
0.0014 |
| 175 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
3 |
0.0014 |
| 176 |
HYPERPHOSPHATAEMIA |
3 |
0.0014 |
| 177 |
BLOOD CULTURE POSITIVE |
4 |
0.0013 |
| 178 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
2 |
0.0013 |
| 179 |
CREATINE KINASE INCREASED |
1 |
0.0013 |
| 180 |
TIC |
7 |
0.0013 |
| 181 |
MYELOSUPPRESSION |
45 |
0.0012 |
| 182 |
DYSBIOSIS |
1 |
0.0012 |
| 183 |
LEUKOCYTURIA |
1 |
0.0012 |
| 184 |
LYMPHOCYTE COUNT DECREASED |
21 |
0.0012 |
| 185 |
ENZYME LEVEL INCREASED |
1 |
0.0012 |
| 186 |
PAPILLARY THYROID CANCER |
2 |
0.0011 |
| 187 |
AREFLEXIA |
3 |
0.0011 |
| 188 |
BLOOD MAGNESIUM INCREASED |
1 |
0.0011 |
| 189 |
HEART TRANSPLANT |
1 |
0.0011 |
| 190 |
VENOUS OCCLUSION |
2 |
0.0011 |
| 191 |
SELECTIVE EATING DISORDER |
1 |
0.0011 |
| 192 |
PREMATURE MENOPAUSE |
1 |
0.0011 |
| 193 |
HYPOPHOSPHATAEMIA |
8 |
0.0011 |
| 194 |
RENAL TUBULAR DISORDER |
3 |
0.0011 |
| 195 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
3 |
0.0011 |
| 196 |
BRAIN STEM HAEMORRHAGE |
1 |
0.0011 |
| 197 |
HYPOPROTEINAEMIA |
2 |
0.0011 |
| 198 |
KLEBSIELLA BACTERAEMIA |
1 |
0.0011 |
| 199 |
PCO2 DECREASED |
1 |
0.0010 |
| 200 |
ACUTE MYELOID LEUKAEMIA |
16 |
0.0010 |
| 201 |
TUMOUR LYSIS SYNDROME |
9 |
0.0010 |
| 202 |
PYURIA |
1 |
0.0010 |
| 203 |
ABDOMINAL TENDERNESS |
5 |
0.0010 |
| 204 |
MESENTERIC VEIN THROMBOSIS |
1 |
0.0010 |
| 205 |
HYPOGONADISM |
1 |
0.0010 |
| 206 |
CATHETER RELATED INFECTION |
1 |
0.0010 |
| 207 |
NEPHROPATHY TOXIC |
11 |
0.0010 |
| 208 |
OSTEOLYSIS |
2 |
0.0010 |
| 209 |
BLAST CELL COUNT INCREASED |
1 |
0.0010 |
| 210 |
SYSTOLIC DYSFUNCTION |
1 |
0.0009 |
| 211 |
HYDROCELE |
1 |
0.0009 |
| 212 |
BACTERIAL SEPSIS |
3 |
0.0009 |
| 213 |
CLAUSTROPHOBIA |
1 |
0.0009 |
| 214 |
EJECTION FRACTION DECREASED |
14 |
0.0009 |
| 215 |
MALNUTRITION |
10 |
0.0009 |
| 216 |
MYOCARDIAL INJURY |
1 |
0.0009 |
| 217 |
SARCOMA |
1 |
0.0009 |
| 218 |
DIFFUSE ALVEOLAR DAMAGE |
1 |
0.0009 |
| 219 |
CARBON DIOXIDE DECREASED |
1 |
0.0009 |
| 220 |
NEPHROGENIC DIABETES INSIPIDUS |
1 |
0.0009 |
| 221 |
NEUTROPHIL COUNT DECREASED |
35 |
0.0009 |
| 222 |
HYPOCHLORAEMIA |
1 |
0.0009 |
| 223 |
HYPERTRIGLYCERIDAEMIA |
5 |
0.0009 |
| 224 |
ESCHERICHIA BACTERAEMIA |
2 |
0.0008 |
| 225 |
FEBRILE INFECTION |
1 |
0.0008 |
| 226 |
LYMPHOPENIA |
12 |
0.0008 |
| 227 |
STREPTOCOCCAL SEPSIS |
1 |
0.0008 |
| 228 |
BLOOD UREA DECREASED |
1 |
0.0008 |
| 229 |
FISTULA DISCHARGE |
1 |
0.0008 |
| 230 |
HYPOCALCAEMIA |
15 |
0.0008 |
| 231 |
NEUTROPENIA |
107 |
0.0008 |
| 232 |
BLOOD BILIRUBIN ABNORMAL |
1 |
0.0008 |
| 233 |
INFUSION SITE IRRITATION |
1 |
0.0008 |
| 234 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
2 |
0.0008 |
| 235 |
CARDIOPULMONARY FAILURE |
3 |
0.0008 |
| 236 |
INTERCEPTED PRODUCT SELECTION ERROR |
1 |
0.0008 |
| 237 |
PNEUMONIA FUNGAL |
3 |
0.0008 |
| 238 |
PACKED RED BLOOD CELL TRANSFUSION |
1 |
0.0008 |
| 239 |
ANION GAP INCREASED |
1 |
0.0007 |
| 240 |
LYMPHOCYTE PERCENTAGE DECREASED |
1 |
0.0007 |
| 241 |
HAEMATOTOXICITY |
7 |
0.0007 |
| 242 |
MUCOUS MEMBRANE DISORDER |
1 |
0.0007 |
| 243 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0007 |
| 244 |
NEUTROPHIL COUNT ABNORMAL |
2 |
0.0007 |
| 245 |
BREAST CANCER STAGE IV |
2 |
0.0007 |
| 246 |
GRANULOCYTOPENIA |
4 |
0.0007 |
| 247 |
NEUTROPENIC SEPSIS |
5 |
0.0007 |
| 248 |
HYPOKALAEMIA |
32 |
0.0007 |
| 249 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
3 |
0.0007 |
| 250 |
ESCHERICHIA SEPSIS |
2 |
0.0007 |
| 251 |
MUCOSAL INFLAMMATION |
18 |
0.0007 |
| 252 |
PANCREATIC ENZYMES INCREASED |
1 |
0.0007 |
| 253 |
EXCESSIVE EYE BLINKING |
1 |
0.0007 |
| 254 |
CARDIOMYOPATHY |
10 |
0.0007 |
| 255 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
19 |
0.0007 |
| 256 |
PARAINFLUENZAE VIRUS INFECTION |
1 |
0.0007 |
| 257 |
ORAL MUCOSAL ERYTHEMA |
1 |
0.0006 |
| 258 |
HYPERTROPHIC CARDIOMYOPATHY |
1 |
0.0006 |
| 259 |
BACTERIAL INFECTION |
12 |
0.0006 |
| 260 |
HEPATIC FUNCTION ABNORMAL |
24 |
0.0006 |
| 261 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
1 |
0.0006 |
| 262 |
BONE MARROW FAILURE |
13 |
0.0006 |
| 263 |
URINE KETONE BODY PRESENT |
1 |
0.0006 |
| 264 |
OPTIC NERVE DISORDER |
1 |
0.0006 |
| 265 |
ACUTE LEUKAEMIA |
1 |
0.0006 |
| 266 |
TROPONIN I INCREASED |
1 |
0.0006 |
| 267 |
MYOCARDIAL NECROSIS MARKER INCREASED |
1 |
0.0006 |
| 268 |
SUPRAVENTRICULAR EXTRASYSTOLES |
2 |
0.0006 |
| 269 |
SPLEEN DISORDER |
1 |
0.0006 |
| 270 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
3 |
0.0006 |
| 271 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 272 |
SKIN HYPOPIGMENTATION |
1 |
0.0006 |
| 273 |
CYTOMEGALOVIRUS TEST POSITIVE |
1 |
0.0006 |
| 274 |
X-RAY ABNORMAL |
1 |
0.0006 |
| 275 |
MONOCYTE COUNT INCREASED |
2 |
0.0006 |
| 276 |
HIDRADENITIS |
5 |
0.0005 |
| 277 |
PNEUMONIA KLEBSIELLA |
1 |
0.0005 |
| 278 |
OTOTOXICITY |
1 |
0.0005 |
| 279 |
STREPTOCOCCAL INFECTION |
3 |
0.0005 |
| 280 |
PROTEIN TOTAL DECREASED |
2 |
0.0005 |
| 281 |
LEUKAEMIA |
5 |
0.0005 |
| 282 |
SEPTIC SHOCK |
23 |
0.0005 |
| 283 |
BLOOD BICARBONATE DECREASED |
1 |
0.0005 |
| 284 |
DEVICE RELATED INFECTION |
8 |
0.0005 |
| 285 |
CARCINOEMBRYONIC ANTIGEN INCREASED |
1 |
0.0005 |
| 286 |
CYTOMEGALOVIRUS CHORIORETINITIS |
1 |
0.0005 |
| 287 |
PULMONARY HAEMORRHAGE |
4 |
0.0005 |
| 288 |
VENOUS THROMBOSIS |
2 |
0.0005 |
| 289 |
HYPERAEMIA |
1 |
0.0005 |
| 290 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
5 |
0.0005 |
| 291 |
MUSCLE CONTRACTURE |
1 |
0.0005 |
| 292 |
EYELID PAIN |
1 |
0.0005 |
| 293 |
POST PROCEDURAL INFECTION |
4 |
0.0005 |
| 294 |
VENTRICULAR TACHYCARDIA |
8 |
0.0005 |
| 295 |
CAPILLARY LEAK SYNDROME |
1 |
0.0005 |
| 296 |
SECOND PRIMARY MALIGNANCY |
4 |
0.0005 |
| 297 |
NEUROGENIC BLADDER |
1 |
0.0005 |
| 298 |
RENAL NEOPLASM |
1 |
0.0005 |
| 299 |
ENTERITIS |
3 |
0.0005 |
| 300 |
PERICARDIAL HAEMORRHAGE |
1 |
0.0005 |
| 301 |
ASPERGILLUS INFECTION |
3 |
0.0005 |
| 302 |
CHRONIC GASTRITIS |
1 |
0.0004 |
| 303 |
SUSPECTED OFF LABEL USE |
2 |
0.0004 |
| 304 |
DISTRIBUTIVE SHOCK |
1 |
0.0004 |
| 305 |
BUNDLE BRANCH BLOCK RIGHT |
2 |
0.0004 |
| 306 |
ENCEPHALITIS |
3 |
0.0004 |
| 307 |
ASPARTATE AMINOTRANSFERASE INCREASED |
23 |
0.0004 |
| 308 |
NEUROLOGICAL DECOMPENSATION |
1 |
0.0004 |
| 309 |
ALANINE AMINOTRANSFERASE INCREASED |
26 |
0.0004 |
| 310 |
TRANSPLANT |
1 |
0.0004 |
| 311 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0004 |
| 312 |
FUNGAL INFECTION |
14 |
0.0004 |
| 313 |
INTRA-ABDOMINAL HAEMORRHAGE |
1 |
0.0004 |
| 314 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
4 |
0.0004 |
| 315 |
LACUNAR INFARCTION |
1 |
0.0004 |
| 316 |
PULSE ABNORMAL |
1 |
0.0004 |
| 317 |
STARING |
1 |
0.0004 |
| 318 |
SINUS BRADYCARDIA |
4 |
0.0004 |
| 319 |
PRODUCT PACKAGING CONFUSION |
1 |
0.0004 |
| 320 |
BLOOD IMMUNOGLOBULIN G DECREASED |
1 |
0.0004 |
| 321 |
STEM CELL TRANSPLANT |
1 |
0.0004 |
| 322 |
PLATELET DISORDER |
1 |
0.0004 |
| 323 |
URINARY TRACT INFECTION BACTERIAL |
1 |
0.0004 |
| 324 |
PATHOLOGICAL FRACTURE |
2 |
0.0004 |
| 325 |
LACTOSE INTOLERANCE |
1 |
0.0004 |
| 326 |
BRONCHOPULMONARY ASPERGILLOSIS |
3 |
0.0004 |
| 327 |
HYPERBILIRUBINAEMIA |
4 |
0.0004 |
| 328 |
VENTRICULAR DYSFUNCTION |
1 |
0.0004 |
| 329 |
THERAPY PARTIAL RESPONDER |
6 |
0.0004 |
| 330 |
SERUM FERRITIN INCREASED |
2 |
0.0004 |
| 331 |
WHITE BLOOD CELL DISORDER |
1 |
0.0004 |
| 332 |
ABDOMINAL MASS |
1 |
0.0004 |
| 333 |
WHITE BLOOD CELL COUNT DECREASED |
40 |
0.0004 |
| 334 |
EMBOLISM |
3 |
0.0004 |
| 335 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
8 |
0.0004 |
| 336 |
PANCYTOPENIA |
20 |
0.0004 |
| 337 |
PROCTITIS |
1 |
0.0004 |
| 338 |
PLATELET COUNT DECREASED |
38 |
0.0004 |
| 339 |
ACUTE PULMONARY OEDEMA |
2 |
0.0004 |
| 340 |
HAEMATEMESIS |
9 |
0.0004 |
| 341 |
OXYGEN SATURATION ABNORMAL |
1 |
0.0004 |
| 342 |
PNEUMATOSIS INTESTINALIS |
1 |
0.0004 |
| 343 |
TUMOUR HAEMORRHAGE |
1 |
0.0004 |
| 344 |
VOMITING PROJECTILE |
1 |
0.0003 |
| 345 |
MYELODYSPLASTIC SYNDROME |
5 |
0.0003 |
| 346 |
COMA SCALE ABNORMAL |
1 |
0.0003 |
| 347 |
GASTROINTESTINAL NECROSIS |
1 |
0.0003 |
| 348 |
NEUROTOXICITY |
6 |
0.0003 |
| 349 |
PERIPHERAL SENSORY NEUROPATHY |
2 |
0.0003 |
| 350 |
STRIDOR |
1 |
0.0003 |
| 351 |
BRAIN HERNIATION |
1 |
0.0003 |
| 352 |
BONE MARROW DISORDER |
1 |
0.0003 |
| 353 |
PORTAL HYPERTENSION |
1 |
0.0003 |
| 354 |
HYPERCALCAEMIA |
4 |
0.0003 |
| 355 |
INFUSION SITE EXTRAVASATION |
2 |
0.0003 |
| 356 |
EPSTEIN-BARR VIRUS INFECTION |
2 |
0.0003 |
| 357 |
HYPONATRAEMIA |
18 |
0.0003 |
| 358 |
ELECTROENCEPHALOGRAM ABNORMAL |
1 |
0.0003 |
| 359 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
5 |
0.0003 |
| 360 |
PRODUCT PREPARATION ISSUE |
2 |
0.0003 |
| 361 |
HYPOGAMMAGLOBULINAEMIA |
2 |
0.0003 |
| 362 |
OTITIS MEDIA |
1 |
0.0003 |
| 363 |
CORONAVIRUS INFECTION |
2 |
0.0003 |
| 364 |
BK VIRUS INFECTION |
1 |
0.0003 |
| 365 |
PNEUMONITIS |
8 |
0.0003 |
| 366 |
NEUTROPHIL COUNT INCREASED |
3 |
0.0003 |
| 367 |
PRODUCT USE ISSUE |
55 |
0.0003 |
| 368 |
BLOOD CREATININE ABNORMAL |
1 |
0.0003 |
| 369 |
HYPOMAGNESAEMIA |
4 |
0.0003 |
| 370 |
TRANSFUSION |
3 |
0.0003 |
| 371 |
MASS |
4 |
0.0003 |
| 372 |
RIGHT VENTRICULAR FAILURE |
2 |
0.0003 |
| 373 |
LIVER INJURY |
7 |
0.0003 |
| 374 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 375 |
SEPSIS |
31 |
0.0003 |
| 376 |
ASPIRATION |
3 |
0.0003 |
| 377 |
BLOOD PHOSPHORUS DECREASED |
1 |
0.0003 |
| 378 |
VIRAL INFECTION |
9 |
0.0003 |
| 379 |
LEUKOENCEPHALOPATHY |
1 |
0.0003 |
| 380 |
HAEMORRHAGE INTRACRANIAL |
4 |
0.0003 |
| 381 |
LEUKOPENIA |
13 |
0.0003 |
| 382 |
METASTASES TO LUNG |
3 |
0.0003 |
| 383 |
ELECTROLYTE IMBALANCE |
3 |
0.0003 |
| 384 |
CELLULITIS |
13 |
0.0003 |
| 385 |
RHINOVIRUS INFECTION |
1 |
0.0003 |
| 386 |
SPINAL CORD COMPRESSION |
1 |
0.0003 |
| 387 |
POLYDIPSIA |
1 |
0.0003 |
| 388 |
OESOPHAGEAL CANDIDIASIS |
1 |
0.0003 |
| 389 |
THROMBOCYTOPENIA |
28 |
0.0003 |
| 390 |
BLOOD DISORDER |
2 |
0.0002 |
| 391 |
HYPERGLYCAEMIA |
9 |
0.0002 |
| 392 |
RECURRENT CANCER |
1 |
0.0002 |
| 393 |
HICCUPS |
2 |
0.0002 |
| 394 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
2 |
0.0002 |
| 395 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 396 |
COAGULOPATHY |
4 |
0.0002 |
| 397 |
HYPERPYREXIA |
1 |
0.0002 |
| 398 |
FEBRILE BONE MARROW APLASIA |
1 |
0.0002 |
| 399 |
ESCHERICHIA URINARY TRACT INFECTION |
1 |
0.0002 |
| 400 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 401 |
UTERINE HAEMORRHAGE |
1 |
0.0002 |
| 402 |
ABSCESS LIMB |
1 |
0.0002 |
| 403 |
HEPATIC PAIN |
1 |
0.0002 |
| 404 |
PRODUCT DISPENSING ISSUE |
1 |
0.0002 |
| 405 |
ANURIA |
2 |
0.0002 |
| 406 |
HEPATIC LESION |
1 |
0.0002 |
| 407 |
OCULAR ICTERUS |
1 |
0.0002 |
| 408 |
MONOPLEGIA |
1 |
0.0002 |
| 409 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 410 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 411 |
CYSTITIS |
7 |
0.0002 |
| 412 |
PNEUMONIA BACTERIAL |
2 |
0.0002 |
| 413 |
ISCHAEMIA |
1 |
0.0002 |
| 414 |
PROTEINURIA |
4 |
0.0002 |
| 415 |
SEROTONIN SYNDROME |
4 |
0.0002 |
| 416 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 417 |
NEOPLASM PROGRESSION |
7 |
0.0002 |
| 418 |
IMMUNODEFICIENCY |
3 |
0.0002 |
| 419 |
HYPOTONIA |
2 |
0.0002 |
| 420 |
HYPERAMMONAEMIA |
1 |
0.0002 |
| 421 |
ANAEMIA |
38 |
0.0002 |
| 422 |
ERYSIPELAS |
1 |
0.0002 |
| 423 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 424 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 425 |
DISEASE PROGRESSION |
23 |
0.0002 |
| 426 |
BENIGN PROSTATIC HYPERPLASIA |
1 |
0.0002 |
| 427 |
VENTRICULAR EXTRASYSTOLES |
2 |
0.0002 |
| 428 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 429 |
FULL BLOOD COUNT ABNORMAL |
2 |
0.0002 |
| 430 |
ANAL ABSCESS |
1 |
0.0002 |
| 431 |
OESOPHAGITIS |
2 |
0.0002 |
| 432 |
WOUND INFECTION |
2 |
0.0002 |
| 433 |
HEPATOTOXICITY |
4 |
0.0002 |
| 434 |
NECROSIS |
1 |
0.0002 |
| 435 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 436 |
BLOOD CALCIUM DECREASED |
2 |
0.0002 |
| 437 |
SKIN TOXICITY |
1 |
0.0002 |
| 438 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
| 439 |
MYOCARDIAL ISCHAEMIA |
2 |
0.0002 |
| 440 |
MYOCARDITIS |
2 |
0.0002 |
| 441 |
CARDIAC FAILURE |
14 |
0.0002 |
| 442 |
NEOPLASM |
2 |
0.0002 |
| 443 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 444 |
MOUTH SWELLING |
1 |
0.0002 |
| 445 |
ENTEROCOLITIS |
1 |
0.0002 |
| 446 |
UPPER RESPIRATORY TRACT INFECTION |
8 |
0.0002 |
| 447 |
HYPERLIPIDAEMIA |
2 |
0.0002 |
| 448 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 449 |
RENAL IMPAIRMENT |
14 |
0.0002 |
| 450 |
HEPATITIS B |
1 |
0.0002 |
| 451 |
AGRANULOCYTOSIS |
3 |
0.0002 |
| 452 |
PHARYNGITIS |
2 |
0.0002 |
| 453 |
SWELLING OF EYELID |
1 |
0.0002 |
| 454 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 455 |
INFECTION |
23 |
0.0002 |
| 456 |
PYREXIA |
54 |
0.0002 |
| 457 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 458 |
DECREASED APPETITE |
36 |
0.0002 |
| 459 |
HAEMORRHOIDS |
3 |
0.0002 |
| 460 |
PANCREATITIS |
8 |
0.0002 |
| 461 |
OFF LABEL USE |
130 |
0.0001 |
| 462 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 463 |
BLOOD BILIRUBIN INCREASED |
4 |
0.0001 |
| 464 |
TACHYPNOEA |
2 |
0.0001 |
| 465 |
ACUTE HEPATIC FAILURE |
2 |
0.0001 |
| 466 |
INFARCTION |
1 |
0.0001 |
| 467 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 468 |
HYPOTENSION |
29 |
0.0001 |
| 469 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 470 |
DISSEMINATED INTRAVASCULAR COAGULATION |
2 |
0.0001 |
| 471 |
LYMPHADENOPATHY |
5 |
0.0001 |
| 472 |
METASTASIS |
1 |
0.0001 |
| 473 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 474 |
UTERINE LEIOMYOMA |
1 |
0.0001 |
| 475 |
ORAL DISORDER |
1 |
0.0001 |
| 476 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 477 |
TRANSAMINASES INCREASED |
3 |
0.0001 |
| 478 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 479 |
PANCREATITIS ACUTE |
3 |
0.0001 |
| 480 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
1 |
0.0001 |
| 481 |
PRODUCT USE IN UNAPPROVED INDICATION |
33 |
0.0001 |
| 482 |
STOMATITIS |
8 |
0.0001 |
| 483 |
HEPATOCELLULAR CARCINOMA |
1 |
0.0001 |
| 484 |
TROPONIN INCREASED |
1 |
0.0001 |
| 485 |
HYPERTHERMIA |
1 |
0.0001 |
| 486 |
LIPASE INCREASED |
1 |
0.0001 |
| 487 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 488 |
TORSADE DE POINTES |
1 |
0.0001 |
| 489 |
DEHYDRATION |
17 |
0.0001 |
| 490 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 491 |
MUSCLE TIGHTNESS |
2 |
0.0001 |
| 492 |
ENCEPHALOPATHY |
3 |
0.0001 |
| 493 |
POLYURIA |
1 |
0.0001 |
| 494 |
METASTASES TO BONE |
2 |
0.0001 |
| 495 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 496 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 497 |
BREAST CANCER STAGE II |
1 |
0.0001 |
| 498 |
HAEMODIALYSIS |
1 |
0.0001 |
| 499 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 500 |
CANDIDA INFECTION |
2 |
0.0001 |
| 501 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 502 |
MALIGNANT NEOPLASM PROGRESSION |
12 |
0.0001 |
| 503 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 504 |
RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 505 |
PLEURAL EFFUSION |
7 |
0.0001 |
| 506 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
| 507 |
HYPOXIA |
4 |
0.0001 |
| 508 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 509 |
LUNG INFILTRATION |
1 |
0.0001 |
| 510 |
BLOOD TRIGLYCERIDES INCREASED |
2 |
0.0001 |
| 511 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 512 |
TACHYCARDIA |
10 |
0.0001 |
| 513 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 514 |
C-REACTIVE PROTEIN INCREASED |
4 |
0.0001 |
| 515 |
RESPIRATORY FAILURE |
8 |
0.0001 |
| 516 |
GRAND MAL CONVULSION |
1 |
0.0001 |
| 517 |
APPENDICITIS |
1 |
0.0001 |
| 518 |
COLITIS |
4 |
0.0001 |
| 519 |
AFFECT LABILITY |
1 |
0.0001 |
| 520 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 521 |
BONE PAIN |
6 |
0.0001 |
| 522 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 523 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 524 |
CYTOKINE RELEASE SYNDROME |
2 |
0.0001 |
| 525 |
HEPATIC FAILURE |
3 |
0.0001 |
| 526 |
TOXIC SKIN ERUPTION |
1 |
0.0001 |
| 527 |
EMPHYSEMA |
1 |
0.0001 |
| 528 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 529 |
BODY TEMPERATURE INCREASED |
2 |
0.0001 |
| 530 |
DRUG ADMINISTRATION ERROR |
3 |
0.0001 |
| 531 |
ABDOMINAL DISTENSION |
10 |
0.0001 |
| 532 |
DRUG-INDUCED LIVER INJURY |
3 |
0.0001 |
| 533 |
DERMATITIS |
2 |
0.0001 |
| 534 |
FOLLICULITIS |
1 |
0.0001 |
| 535 |
MOUTH ULCERATION |
2 |
0.0001 |
| 536 |
SUDDEN DEATH |
1 |
0.0001 |
| 537 |
BREAST PAIN |
1 |
0.0001 |
| 538 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 539 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 540 |
STAPHYLOCOCCAL INFECTION |
3 |
0.0001 |
| 541 |
ORAL PAIN |
2 |
0.0001 |
| 542 |
SKIN INFECTION |
1 |
0.0001 |
| 543 |
FISTULA |
1 |
0.0001 |
| 544 |
EYE INFECTION |
1 |
0.0001 |
| 545 |
DELIRIUM |
3 |
0.0001 |
| 546 |
EYELID OEDEMA |
1 |
0.0001 |
| 547 |
ARRHYTHMIA |
4 |
0.0001 |
| 548 |
CHOLECYSTITIS |
1 |
0.0001 |
| 549 |
THYROID CANCER |
1 |
0.0001 |
| 550 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 551 |
RESPIRATORY DEPRESSION |
1 |
0.0001 |
| 552 |
INTERCEPTED PRODUCT PREPARATION ERROR |
1 |
0.0001 |
| 553 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 554 |
ILEUS |
1 |
0.0001 |
| 555 |
TOOTH EXTRACTION |
1 |
0.0001 |
| 556 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 557 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 558 |
BRAIN OEDEMA |
1 |
0.0001 |
| 559 |
VOMITING |
37 |
0.0001 |
| 560 |
WHITE BLOOD CELL COUNT INCREASED |
3 |
0.0001 |
| 561 |
MYDRIASIS |
1 |
0.0001 |
| 562 |
ANOREXIA |
1 |
0.0001 |
| 563 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 564 |
ABDOMINAL PAIN |
18 |
0.0001 |
| 565 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 566 |
BEDRIDDEN |
1 |
0.0001 |
| 567 |
GASTRITIS |
2 |
0.0001 |
| 568 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 569 |
NEOPLASM MALIGNANT |
5 |
0.0001 |
| 570 |
NEUROPATHY PERIPHERAL |
7 |
0.0001 |
| 571 |
DRUG TOXICITY |
1 |
0.0001 |
| 572 |
RESPIRATORY DISTRESS |
2 |
0.0001 |
| 573 |
ACUTE KIDNEY INJURY |
11 |
0.0001 |
| 574 |
HAEMOPTYSIS |
2 |
0.0001 |
| 575 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 576 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 577 |
GASTROENTERITIS |
1 |
0.0001 |
| 578 |
HAEMOGLOBIN DECREASED |
7 |
0.0001 |
| 579 |
ASCITES |
2 |
0.0001 |
| 580 |
RENAL FAILURE |
9 |
0.0001 |
| 581 |
PSYCHOTIC DISORDER |
2 |
0.0001 |
| 582 |
PULMONARY MASS |
1 |
0.0001 |
| 583 |
GASTROINTESTINAL DISORDER |
6 |
0.0001 |
| 584 |
EPISTAXIS |
5 |
0.0001 |
| 585 |
APHASIA |
2 |
0.0001 |
| 586 |
OSTEOPENIA |
1 |
0.0001 |
| 587 |
PNEUMONIA |
21 |
0.0001 |
| 588 |
NERVOUS SYSTEM DISORDER |
2 |
0.0001 |
| 589 |
BRAIN FOG |
1 |
0.0001 |
| 590 |
CYANOSIS |
1 |
0.0001 |
| 591 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 592 |
DRUG INTERACTION |
10 |
0.0001 |
| 593 |
PRODUCTIVE COUGH |
3 |
0.0001 |
| 594 |
ABSCESS |
1 |
0.0001 |
| 595 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 596 |
METABOLIC ACIDOSIS |
2 |
0.0001 |
| 597 |
CARDIAC FAILURE CONGESTIVE |
5 |
0.0001 |
| 598 |
DRUG INTOLERANCE |
6 |
0.0001 |
| 599 |
NIGHT SWEATS |
2 |
0.0001 |
| 600 |
BLOOD CREATININE INCREASED |
4 |
0.0001 |
| 601 |
CHOLELITHIASIS |
2 |
0.0001 |
| 602 |
OSTEONECROSIS |
2 |
0.0001 |
| 603 |
MULTIPLE FRACTURES |
1 |
0.0001 |
| 604 |
DRUG LEVEL INCREASED |
1 |
0.0001 |
| 605 |
CYTOMEGALOVIRUS INFECTION |
1 |
0.0001 |
| 606 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 607 |
CHILLS |
7 |
0.0001 |
| 608 |
PERICARDITIS |
1 |
0.0001 |
| 609 |
HEMIPARESIS |
1 |
0.0001 |
| 610 |
HEPATIC ENZYME INCREASED |
4 |
0.0001 |
| 611 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 612 |
HYPERTENSION |
12 |
0.0001 |
| 613 |
BRADYCARDIA |
3 |
0.0001 |
| 614 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 615 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 616 |
NAUSEA |
43 |
0.0001 |
| 617 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 618 |
GASTRIC ULCER |
1 |
0.0001 |
| 619 |
CHOLESTASIS |
1 |
0.0001 |
| 620 |
SEIZURE |
6 |
0.0001 |
| 621 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 622 |
DYSTONIA |
1 |
0.0001 |
| 623 |
ATRIAL FIBRILLATION |
5 |
0.0001 |
| 624 |
ORAL HERPES |
1 |
0.0001 |
| 625 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
2 |
0.0001 |
| 626 |
CONSTIPATION |
11 |
0.0001 |
| 627 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 628 |
SYNCOPE |
5 |
0.0000 |
| 629 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 630 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 631 |
CHEST DISCOMFORT |
5 |
0.0000 |
| 632 |
INFLUENZA LIKE ILLNESS |
4 |
0.0000 |
| 633 |
CARDIAC ARREST |
4 |
0.0000 |
| 634 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 635 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 636 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 637 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 638 |
MELAENA |
1 |
0.0000 |
| 639 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 640 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 641 |
CHROMATURIA |
1 |
0.0000 |
| 642 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 643 |
SHOCK |
1 |
0.0000 |
| 644 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 645 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 646 |
DYSPHAGIA |
4 |
0.0000 |
| 647 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 648 |
COMA |
2 |
0.0000 |
| 649 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 650 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 651 |
PRESYNCOPE |
1 |
0.0000 |
| 652 |
AGITATION |
3 |
0.0000 |
| 653 |
BRONCHITIS |
3 |
0.0000 |
| 654 |
WEIGHT INCREASED |
9 |
0.0000 |
| 655 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 656 |
HYPOPHAGIA |
1 |
0.0000 |
| 657 |
DRUG RESISTANCE |
1 |
0.0000 |
| 658 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 659 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 660 |
DEAFNESS |
1 |
0.0000 |
| 661 |
BREAST CANCER FEMALE |
1 |
0.0000 |
| 662 |
DIARRHOEA |
24 |
0.0000 |
| 663 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 664 |
TREATMENT FAILURE |
3 |
0.0000 |
| 665 |
DIVERTICULITIS |
1 |
0.0000 |
| 666 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 667 |
WOUND |
1 |
0.0000 |
| 668 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 669 |
PAIN IN JAW |
1 |
0.0000 |
| 670 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 671 |
HERPES ZOSTER |
2 |
0.0000 |
| 672 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 673 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 674 |
BREAST CANCER |
3 |
0.0000 |
| 675 |
ASTHENIA |
12 |
0.0000 |
| 676 |
PULMONARY EMBOLISM |
3 |
0.0000 |
| 677 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 678 |
DEEP VEIN THROMBOSIS |
2 |
0.0000 |
| 679 |
ALOPECIA |
6 |
0.0000 |
| 680 |
IMPAIRED HEALING |
1 |
0.0000 |
| 681 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 682 |
SKIN DISORDER |
1 |
0.0000 |
| 683 |
URINARY RETENTION |
1 |
0.0000 |
| 684 |
TOXICITY TO VARIOUS AGENTS |
5 |
0.0000 |
| 685 |
CONDITION AGGRAVATED |
9 |
0.0000 |
| 686 |
URINARY TRACT INFECTION |
5 |
0.0000 |
| 687 |
HAEMATURIA |
1 |
0.0000 |
| 688 |
HYPERKALAEMIA |
1 |
0.0000 |
| 689 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 690 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 691 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 692 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 693 |
DYSURIA |
1 |
0.0000 |
| 694 |
HALLUCINATION |
2 |
0.0000 |
| 695 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 696 |
DIABETES MELLITUS |
2 |
0.0000 |
| 697 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 698 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 699 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 700 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 701 |
BLINDNESS |
1 |
0.0000 |
| 702 |
OSTEOPOROSIS |
1 |
0.0000 |
| 703 |
POLLAKIURIA |
1 |
0.0000 |
| 704 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 705 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 706 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 707 |
HYPOACUSIS |
1 |
0.0000 |
| 708 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 709 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 710 |
VISION BLURRED |
3 |
0.0000 |
| 711 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 712 |
RENAL DISORDER |
1 |
0.0000 |
| 713 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 714 |
COUGH |
6 |
0.0000 |
| 715 |
DRUG INEFFECTIVE |
28 |
0.0000 |
| 716 |
BLOOD GLUCOSE INCREASED |
4 |
0.0000 |
| 717 |
GAIT DISTURBANCE |
4 |
0.0000 |
| 718 |
RASH |
9 |
0.0000 |
| 719 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 720 |
LUNG DISORDER |
1 |
0.0000 |
| 721 |
DYSPEPSIA |
2 |
0.0000 |
| 722 |
HYPOAESTHESIA |
3 |
0.0000 |
| 723 |
THERAPY CESSATION |
1 |
0.0000 |
| 724 |
ERYTHEMA |
4 |
0.0000 |
| 725 |
ILLNESS |
2 |
0.0000 |
| 726 |
FATIGUE |
15 |
0.0000 |
| 727 |
HAEMORRHAGE |
2 |
0.0000 |
| 728 |
ECZEMA |
1 |
0.0000 |
| 729 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 730 |
DEPRESSED MOOD |
1 |
0.0000 |
| 731 |
RASH PRURITIC |
1 |
0.0000 |
| 732 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 733 |
BLISTER |
1 |
0.0000 |
| 734 |
CONVULSION |
1 |
0.0000 |
| 735 |
DYSPHONIA |
1 |
0.0000 |
| 736 |
SURGERY |
1 |
0.0000 |
| 737 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 738 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 739 |
DISCOMFORT |
1 |
0.0000 |
| 740 |
CHEST PAIN |
3 |
0.0000 |
| 741 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 742 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 743 |
INSOMNIA |
4 |
0.0000 |
| 744 |
HEADACHE |
9 |
0.0000 |
| 745 |
BURNING SENSATION |
1 |
0.0000 |
| 746 |
INJURY |
1 |
0.0000 |
| 747 |
SLEEP DISORDER |
1 |
0.0000 |
| 748 |
DYSPNOEA |
8 |
0.0000 |
| 749 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 750 |
ANXIETY |
4 |
0.0000 |
| 751 |
MOBILITY DECREASED |
1 |
0.0000 |
| 752 |
UNDERDOSE |
1 |
0.0000 |
| 753 |
BACK PAIN |
3 |
0.0000 |
| 754 |
DEATH |
11 |
0.0000 |
| 755 |
THROMBOSIS |
1 |
0.0000 |
| 756 |
TREMOR |
2 |
0.0000 |
| 757 |
URTICARIA |
2 |
0.0000 |
| 758 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 759 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 760 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 761 |
WEIGHT DECREASED |
3 |
0.0000 |
| 762 |
SOMNOLENCE |
2 |
0.0000 |
| 763 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 764 |
FLUSHING |
1 |
0.0000 |
| 765 |
INFLUENZA |
1 |
0.0000 |
| 766 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 767 |
PALPITATIONS |
1 |
0.0000 |
| 768 |
DIZZINESS |
4 |
0.0000 |
| 769 |
PRURITUS |
3 |
0.0000 |
| 770 |
HYPERHIDROSIS |
1 |
0.0000 |
| 771 |
PSORIASIS |
1 |
0.0000 |
| 772 |
MALAISE |
3 |
0.0000 |
| 773 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 774 |
HOSPITALISATION |
1 |
0.0000 |
| 775 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 776 |
PARAESTHESIA |
1 |
0.0000 |
| 777 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 778 |
COVID-19 |
1 |
0.0000 |
| 779 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 780 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 781 |
FEELING ABNORMAL |
1 |
0.0000 |
| 782 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 783 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 784 |
ARTHRALGIA |
1 |
0.0000 |
| 785 |
PAIN |
1 |
0.0000 |